BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeng FR, Ling Y, Yang J, Tian XC, Yang X, Luo RC. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer: a meta-analysis. Tumour Biol. 2013;34:555-563. [PMID: 23188703 DOI: 10.1007/s13277-012-0581-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Abd El-hassib DM, Zidan MA, El Amawy MM, Hegazy HA, Ameen SG. Polymorphism of XRCC1 Arg399Gln may predict for development of end-stage renal disease. A PCR confirmed case-control study. Meta Gene 2021. [DOI: 10.1016/j.mgene.2021.100915] [Reference Citation Analysis]
2 Mishchuk-reka Y, Kharkivska Y, Serga S, Stakhovsky E, Stakhovskyi O, Kononenko O, Koliada O, Ponomarova O, Gulkovskyi R, Ostapchenko L, Demydov S, Kozeretska I. An association of XRCC1 codon 399 polymorphism (RS25487) with bladder and prostate cancer susceptibility in the Ukrainian population. Meta Gene 2020;24:100696. [DOI: 10.1016/j.mgene.2020.100696] [Reference Citation Analysis]
3 Salimzadeh H, Lindskog EB, Gustavsson B, Wettergren Y, Ljungman D. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival. BMC Cancer 2020;20:409. [PMID: 32397974 DOI: 10.1186/s12885-020-06924-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Perdamaian TK. Recent evidence on modifiable and non-modifiable risk factors for colorectal cancer (CRC): a systematic synopsis of meta-analyses from 2015 to 2017. Med J Indones 2019;28:188-95. [DOI: 10.13181/mji.v28i2.2679] [Reference Citation Analysis]
5 Lau TP, Lian LH, Cheah PL, Looi LM, Roslani AC, Goh KL, Lee PC, Chua KH. Lack of correlation between X-ray repair cross-complementing group 1 gene polymorphisms and the susceptibility to colorectal cancer in a Malaysian cohort. Eur J Cancer Prev 2017;26:506-10. [PMID: 28059856 DOI: 10.1097/CEJ.0000000000000336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Tan SC. Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition. J Gene Med 2018;20:e3010. [PMID: 29424105 DOI: 10.1002/jgm.3010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
7 Jin SS, Song WJ. Association between MDR1 C3435T polymorphism and colorectal cancer risk: A meta-analysis. Medicine (Baltimore) 2017;96:e9428. [PMID: 29390571 DOI: 10.1097/MD.0000000000009428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Mirsane SA, Shafagh S. The Relationship Between XRCC1 Arg399Gln Polymorphism, Alcohol Consumption and Colorectal Cancer: One of the Alcohol Forbidding Reasons in Islam. Gene Cell Tissue 2016;3. [DOI: 10.17795/gct-40607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Yan J, Wang X, Tao H, Deng Z, Yang W, Lin F. Meta-Analysis of the Relationship between XRCC1-Arg399Gln and Arg280His Polymorphisms and the Risk of Prostate Cancer. Sci Rep 2015;5:9905. [PMID: 25927275 DOI: 10.1038/srep09905] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
10 Qin CJ, Xu KW, Chen ZH, Zhai ET, He YL, Song XM. XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis. Tumour Biol 2015;36:461-6. [PMID: 25582318 DOI: 10.1007/s13277-015-3054-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
11 Zhang SH, Wang LA, Li Z, Peng Y, Cun YP, Dai N, Cheng Y, Xiao H, Xiong YL, Wang D. APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans. World J Gastroenterol 2014; 20(26): 8700-8708 [PMID: 25024628 DOI: 10.3748/wjg.v20.i26.8700] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
12 Liu C, Yin Q, Jiao G, Zhou X, Ying M, Gao W, Hu J, Wei L, Wang N, Wang Y. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies. DNA Cell Biol 2014;33:378-87. [PMID: 24694255 DOI: 10.1089/dna.2013.2269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Sebio A, Lenz H. Clinical importance of recently discovered gene variants in colon cancer recurrence and prognosis. Colorectal Cancer 2014;3:147-162. [DOI: 10.2217/crc.14.2] [Reference Citation Analysis]
14 Kang M, Ding X, Xu M, Zhu H, Liu S, Wang M, Wu D, Tong N, Gong W, Zhou J, Zhang Z. Genetic variation rs10484761 on 6p21.1 derived from a genome-wide association study is associated with gastric cancer survival in a Chinese population. Gene 2014;536:59-64. [DOI: 10.1016/j.gene.2013.11.087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
15 Wu H, Hu J, Liu B, Tao Y, Zhou X, Yuan X. Lack of association between interleukin-4 -524C>T polymorphism and colorectal cancer susceptibility. Tumour Biol 2014;35:3657-62. [PMID: 24318972 DOI: 10.1007/s13277-013-1484-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Shen E, Liu C, Wei L, Hu J, Weng J, Yin Q, Wang Y. The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis. Tumour Biol. 2014;35:2529-2535. [PMID: 24254302 DOI: 10.1007/s13277-013-1334-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hu Y, Sun Z, Zhang A, Zhang J. SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer. Tumour Biol 2014;35:695-9. [PMID: 23949881 DOI: 10.1007/s13277-013-1095-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
18 Guo Q, Yang W, Zhai J, Han F, Wang C. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures. Tumor Biol 2013;34:2989-94. [DOI: 10.1007/s13277-013-0863-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
19 Zhang Y, Wang Y, Wu J, Li LJ. XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis. Tumour Biol 2013;34:2321-7. [PMID: 23681796 DOI: 10.1007/s13277-013-0779-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
20 Qian J, Song Z, Lv Y, Huang X. CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls. Tumour Biol. 2013;34:2225-2231. [PMID: 23636797 DOI: 10.1007/s13277-013-0762-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
21 Peng H, Xie SK, Huang MJ, Ren DL. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis. Tumour Biol 2013;34:2389-95. [PMID: 23595220 DOI: 10.1007/s13277-013-0788-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li Y, Li S, Wu Z, Hu F, Zhu L, Zhao X, Cui B, Dong X, Tian S, Wang F. Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population. Med Oncol. 2013;30:505. [PMID: 23430444 DOI: 10.1007/s12032-013-0505-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]